baber/WOPTO huggingface dataset:
Patent AT-E154469-T1 (AT)
Inventor: QUIGG FRED L
IPC: H01L21/336
Filed: 1991-01-22
Granted: 1997-06-15
Abstract: In one embodiment, a vertical MOSFET is formed having a lower gate portion (124) overlying the channel region of the MOSFET and separated from the channel region by a thin gate oxide layer (90). An upper gate portion (120) is formed overlying the drain of the MOSFET and separated from the drain by a relatively thick oxide layer (86). In this particular embodiment, since the dielectric thickness between the upper gate portion (120) and the drain (82) is relatively large, the MOSFET exhibits a lower gate-drain capacitance (CGD) value, while the threshold voltage of the MOSFET remains relatively unchanged. The upper gate portion (120) may be electrically connected to the lower gate portion (124) or may be electrically isolated from the lower gate portion (124). A preferred method of forming the resulting MOSFET having this lowered CGD allows the source (92) and body regions (88) to be precisely aligned with the drain edge of the lower gate portion (124).
Patent AT-E181157-T1 (AT)
Inventor: WILSON MICHAEL
IPC: A61L2/00
Filed: 1991-03-26
Granted: 1999-06-15
Abstract: Methods of maintaining or providing sterile or specific pathogen free environments are disclosed. The methods involve the use of semi-permeable membrane materials between the sterile or pathogen free environment and surrounding potentially hostile environments. One particular method and apparatus is described for introducing drugs or other secondary substances to a sterile liquid for example for transfusion to a patient. The apparatus has a first port (4) for connection to a container of sterile solution second port (5) for connection to a transfer tuber and a third port (9) for introduction of the secondary substance. The connection between the third port and the other ports is by way of a semi-permeable membrane (11) selected to permit the passage of the secondary substance while preventing the ingress of pathogens or other potentially harmful organisms. <IMAGE>
Patent AT-E131175-T1 (AT)
Inventor: IGARASHI KOICHI - SHIMOGAMO-MI
IPC: A61K38/00
Filed: 1991-04-25
Granted: 1995-12-15
Abstract: Disclosed are (1) a water-soluble mutein of an animal protein having activity as a receptor for a fibroblast growth factor (FGF) protein, (2) a recombinant DNA having a nucleotide sequence coding for the above water-soluble mutein, (3) a vector containing the above recombinant DNA, (4) a transformant transformed with the above vector, and (5) a process for producing the water-soluble mutein which comprises cultivating the above transformant in a culture medium, the mutein being useful as therapeutic agents or to enhance cell proliferation activity.
Patent AT-E113418-T1 (AT)
Inventor: SORIANO LOUIS
IPC: B23P19/02
Filed: 1991-11-14
Granted: 1994-11-15
Abstract: A guiding method and device for automatically inserting a male piece into a female piece, these pieces being generally cylindrical or prismatic with axis (zz') and mounted on supports for moving them relative to each other along three orthonormal translational axes, one of which is parallel to the axis (zz') and forms the insertion axis. Said male piece (1) is flexibly in rotation mounted onthe other two axes relative to its support (3) and the device includes a guide (4) moving relatively along a plane (PP') which is perpendicular to the axis (zz') above the socket (2) of the female piece, so that it covers a portion of the opening thereof. When said male piece (1) is brought into abutment with said guide, it tilts at a predetermined angle.
Patent AT-E215966-T1 (AT)
Inventor: HANNUM CHARLES H
IPC: C12N15/09
Filed: 1989-05-26
Granted: 2002-04-15
Abstract: A substantially purified interleukin-1 inhibitor (IL-li which is active against interleukin-1 alpha or interleukin-1 beta or both of these substances. A recombinant-DNA method for the production of an interleukin-1 inhibitor (IL-li), and an isolated DNA sequence encoding a physiologically functional interleukin-1 inhibitor (IL-li). <IMAGE>
Patent AT-E174702-T1 (AT)
Inventor: RACKOW ULRIKE
IPC: G06F17/27
Filed: 1992-09-12
Granted: 1999-01-15
Abstract: The invention concerns a text translation system, wherein the memory of a computer system stores the word type, the semantic type, a juncture code, a position code, a transfer code, as well as the associated translation into the target language for each word of the source language. By means of the juncture code and the position code, the compounds of the source language are decomposed into the words of which they consist. For these words the associated translations into the target language are read from the memory. The translations are then compounded following standard translation rules. For this purpose, translation peculiarities of compounds are taken into account by the transfer code. The invention eliminates storing compounds in the memory of the computer system. Instead, only the individual words of which the compounds consist are stored. This greatly reduces the memory space required for storing all the words of a source language and simultaneously increases the processing speed of the text translation system. <IMAGE>
Patent AT-E129221-T1 (AT)
Inventor: HOOYKAAS CAREL WILLEM JAN
IPC: C04B2/06
Filed: 1992-02-14
Granted: 1995-11-15
Abstract: The invention relates to a method of deactivating granules containing at least calcium oxide present in slag material by bringing the slag material, optionally in a comminuted form, into contact with water in the presence of a substance which prevents the formation of a thin layer which retards water permeation around the said granules. The deactivation is expediently carried out at elevated temperature, preferably at a temperature of at least 70 DEG C and a relative humidity of at least 80%. The particle size of the slag material preferably is from 1 to 50 mm.
Patent AT-E139445-T1 (AT)
Inventor: HUGHES JULIA MARY
IPC: A61K8/00
Filed: 1992-03-31
Granted: 1996-07-15
Abstract: The invention relates to the prevention or reduction of periodontitis and alveolar bone loss. It has been found that by the use of a medicament that comprises a zinc-ion containing compound such as zinc citrate or zinc glycinate, alveolar bone loss can be reduced. Suitable medicaments are in the form of toothpastes and mouthrinses.
Patent AT-E197049-T1 (AT)
Inventor: DOECKE CHRISTOPHER WILIAM
IPC: C07B57/00
Filed: 1992-07-17
Granted: 2000-11-15
Abstract: A process for isolating a  beta -lactam compound with about 100% enantiomeric purity, of the formula <CHEM> where R1 is CH3, t-C4H9, C6H5CH2O, C6H5, C6H5OCH2 or C6H5CH2; from a haloalkane solvent, comprising diluting the solution with methyl t-butyl ether or methanol to precipitate the product. The products thus obtained are key intermediates in the synthesis of antibiotic agents. The process is appropriiate for large scale production.
Patent AT-E138451-T1 (AT)
Inventor: ERICSON STEVE
IPC: F04D7/02
Filed: 1992-09-09
Granted: 1996-06-15
Abstract: A centrifugal pump having an impeller (38) which is associated with a motor and a drive shaft (16,14) and that is enclosed within a housing (28). The housing (28) is mounted in surrounding, spaced and non-contacting relationship, with respect to the impeller (38) and drive shaft (14) contains fluid inlet (26,26') through which fluids are directed by the impeller (28) to an outlet from the housing (28). Also provided is a pump which operates from remote locations.
Patent AT-E135853-T1 (AT)
Inventor: WITTINE HANNES
IPC: G02B6/44
Filed: 1992-07-27
Granted: 1996-04-15
Abstract: A sleeve for holding cable splices consists of two half-shells (1 and 2) which are connected to one another. The sleeve which is formed by the half-shells (1 and 2) has through-openings on its end surfaces for the cables which are inserted into the sleeve, cable-insertion connecting pieces (7) or closure caps (10) being mounted on the through-openings. In order to seal the two half-shells (1 and 2) to one another, elongated seals (20) are provided on the longitudinal side edges of the half-shells and U-shaped seals (30) are provided in the region between the through-openings for the cables. The seals (20 and 30), which are inserted into corresponding grooves in the half-shells, have broadened heads which lie in the region of the end surfaces of the half-shells (1 and 2). In this case, the ends of the heads are bridged with respect to one another by means of annular seals which are provided between the cable-insertion connecting pieces (7) and the end surfaces of the sleeve. It is thus ensured that the sleeve is completely sealed to the exterior, all round. <IMAGE>
Patent AT-E142340-T1 (AT)
Inventor: KNOLL WOLFGANG
IPC: G01N33/53
Filed: 1991-12-12
Granted: 1996-09-15
Abstract: A binding matrix contains a substrate upon which are adsorbed by means of anchoring groups solid phase reactants capable of binding at least one free reaction partner. The solid-phase reactant forms a diluted and essentially laterally homogeneous binding layer on the surface of the substrate. In addition, according to an assaying process for an analyte in an assay solution, a solid-phase reactant that forms a component of the disclosed binding matrix is used. The specific binding reaction is preferably determined by optical reflection techniques.
Patent AT-E182152-T1 (AT)
Inventor: LIPPMAN MARC E
IPC: A61K38/00
Filed: 1992-01-13
Granted: 1999-07-15
Abstract: The present invention relates to erbB-2 ligands and function derivatives thereof which are capable of binding to the erbB-2 transmembrane protein but fail to bind to epidermal growth factor receptor. The present invention further pertains to anti-ligand molecules capable of recognizing and binding to the erbB-2 ligand molecule and to screening assays for such ligands. The present invention additionally relates to uses for the erbB-2 ligand, the anti-ligand molecules and the screening assays.
Patent AT-E128460-T1 (AT)
Inventor: SKUBALLA WERNER
IPC: A61K31/557
Filed: 1992-02-24
Granted: 1995-10-15
Abstract: The invention discloses new leukotriene B4 derivatives of formula (I), wherein R?1 stands for CH2?OH, CH3?, CF3?, COOR?5, CONR?6R?7, or R?1 together with R?2 stands for a carbonyl group, R?2 and R?3 are the same or different and stand for H or an organic acid residue containing 1 to 15 carbon atoms, R?4 stands for H, C1?-C10? alkyl, possibly substituted one or more times by chlorine or bromine, C3?-C10? cycloalkyl, a C6?-C10? aryl residue possibly substituted one or more times by chlorine, bromine or phenyl, C1?-C4? alkyl, C1?-C4? alkoxy, fluoromethyl, chloromethyl, trifluoromethyl, carboxy or hydroxy, or a 5- or 6-membered aromatic heterocyclic ring with at least one heteroatom, R?5 stands for hydrogen, C1?-C10? alkyl, C3?-C10? cycloalkyl, a C6?-C10? aryl residue possibly substituted one to three times by chlorine, bromine or phenyl, C1?-C4? alkyl, C1?-C4? alkoxy, fluoromethyl, chloromethyl, trifluoromethyl, carboxy or hydroxy, CH2?-CO-(C6?-C10?) aryl or a 5- or 6-membered ring with at least one heteroatom, A stands for a trans,trans-CH=CH-CH=CH, a -CH2?CH2?-CH=CH- or a tetramethylene group, B stands for a C1?-C10? straight-chain or branched-chain alkylene group, possibly substituted by fluorine, or the group of formula (a), D stands for a direct bond, oxygen, sulphur, -C=C-, -CH=CR8? or, together with B, for a direct bond, R6? and R7? are the same or different and stand for H or C1?-C4? alkyl or R7? stands for H and R6? stands for C1?-C10? alkanoyl or C1?-C10? alkanesulphonyl, R8? stands for H, C1?-C5? alkyl, chlorine or bromine, n is equal to 3 to 5 and, when R5? stands for hydrogen, their salts with physiologically tolerable bases and their cyclodextrin clathrates.
Patent AT-E137711-T1 (AT)
Inventor: PATTERSON SAM H
IPC: B62M9/127
Filed: 1992-03-18
Granted: 1996-05-15
Abstract: A bicycle gear shifting system having rotatable front and rear handgrip shift actuators (408,408h,408c,410) operatively associated with control cables (415,417) for shifting respective front and rear derailleur mechanisms. A shifter rotator (412,412b,412c,413) drives a separate "jack spool" (436,436a,436b,436c) which in turn actuates the control cable (415,417). A cam on the jack spool (436,436a,436b,436c) is configured so as to substantially compensate for increasing force of the derailleur return spring during down-shifting. Compensation is provided in the shift actuator for various lost motions in the derailleur shifting mechanisms and control cable systems. The shift actuator (408,408b,408c,410) also provides overshift movement of the derailleur mechanisms in the down-shifting direction so as to overshift the bicycle chain a sufficient amount beyond the destination derailleur sprocket so that the chain will approach the destination sprocket in the same direction as it would in the up-shifting direction. The shift actuator (408,408b,408c,410) also provides equalization for the higher derailleur return spring force during down-shifting than during up-shifting, and allow fine-tuning to avoid chain rasp, which is particularly important for "cross-over" riding.
Patent AT-E163079-T1 (AT)
Inventor: STALHANE CARL HENRIK
IPC: F23D14/14
Filed: 1992-06-29
Granted: 1998-02-15
Abstract: PCT No. PCT/SE92/00483 Sec. 371 Date May 3, 1994 Sec. 102(e) Date May 3, 1994 PCT Filed Jun. 29, 1992 PCT Pub. No. WO93/01448 PCT Pub. Date Jan. 21, 1993The invention discloses a gas powered burner with perforated ceramic elements which are adjustable in their planes and/or essentially perpendicular to their planes. The burner dan be adjusted so as to emit uniform infra-red radiation with good precision within the wavelength band, irrespective of how the burner is angled or located.
Patent AT-E160595-T1 (AT)
Inventor: LAITINEN MAURI
IPC: B29C70/06
Filed: 1992-09-11
Granted: 1997-12-15
Abstract: The object of the invention is a method for manufacturing a laminating reinforced fibre structure (1), in which fibre layers (7, 8) made of cross-woven warp or weft yarn bundles are manufactured as a warp structure, these being tied together with ties (9) and a filler (4) is placed in the channel formed by the layers one top of each other and the ties. In accordance with the invention two fiber layers (7, 8) one top of one another are woven together in a manner that is as such known, in such a way that the warp (2) or alternatively weft (3) bundles of yarns run in turn in the upper and lower structures thus forming large channels in relation to the size of the fabric and pieces impermeable to a binder substance is used as a filler (4).
Patent AT-E137881-T1 (AT)
Inventor: BESENHARD JUERGEN OTTO
IPC: B05D7/02
Filed: 1992-09-11
Granted: 1996-05-15
Abstract: The invention concerns a method of manufacturing highly conducting composites, the method being characterized by the following steps: a) contacting a powder or fibers with an aqueous solution containing an appreciably water-soluble high-molecular substance, b) optionally washing with water, c) contacting with a dispersion containing finely particulate electrically conducting material, wetting agents (surfactants) and an ionogenic metal compound, d) optionally washing with water and e) molding to required shape.
Patent AT-E158437-T1 (AT)
Inventor: KELLER KLAUS DIPL-ING FH
IPC: G06F19/00
Filed: 1993-04-22
Granted: 1997-10-15
Abstract: In conventional dictation apparatuses, magnetic tape memories are used for storing the dictated piece. It is also possible to store the dictated piece in a semiconductor memory. A dictation apparatus having a semiconductor memory of a storage capacity which corresponds to the storage capacity of a magnetic tape memory is a relatively expensive apparatus. The combination according to the invention of magnetic tape memory and semiconductor memory combines the advantages of both memory families and permits the editing of a dictated piece in a surprisingly simple way. The parallel serial storing in magnetic tape memory and semiconductor memory allows subsequent editing in virtually any way desired of the spoken text, such as deleting a part of the text without intermediate pauses, insertion of a part of text etc., without having to accept an overshoot time caused by the semiconductor memory, as in the case of the subject of German Offenlegungsschrift 39 21 942. The circuit arrangement according to the invention permits the implementation of corrections at any desired points of the text and of any desired length. Due to the storage of the edited dictated piece in the magnetic tape memory, conventional playback apparatuses can continue to be used for listening. <IMAGE>
Patent AT-E196602-T1 (AT)
Inventor: SCHAEL WILFRIED DR-ING
IPC: B01D61/26
Filed: 1993-06-25
Granted: 2000-10-15
Abstract: The process provides a possibility for individual adaptation of the composition of the dialysis liquid to different therapeutic requirements by using a basic concentrate, which predominates by far in terms of quantity, contains mainly sodium chloride and sodium bicarbonate and has a uniform standardised composition and which provides a sodium ion concentration which is at the lower limit of the physical range, and an individually selected additional concentrate which provides the supplementary amount of sodium ions and additionally contains potassium, calcium and magnesium salts and glucose in individually adapted dosage. The individual additional concentrate is a 120- to 250-fold liquid concentrate, so that an easily handled amount of, typically, 1 litre suffices for one dialysis treatment. The uniform basic concentrate is a prefabricated 15- to 18-fold liquid concentrate or is supplied as dry substance which is dissolved in water only at the place of use, and the liquid concentrate or the solution is fed through a supply system to a plurality of dialysers. <IMAGE>
Patent AT-E138637-T1 (AT)
Inventor: SOBOTTA GEORG DR-ING
IPC: C07C69/06
Filed: 1993-11-04
Granted: 1996-06-15
Abstract: A process for the production of methyl formate by carbonylation of methanol in the presence of sodium methoxide or potassium methoxide as a catalyst is improved by reduction of the catalyst consumption and intensification of the process. For this purpose, a certain amount of sodium oxaperfluoro-alkanesulfonate or potassium oxaperfluoroalkanesulfonate and up to 10% by weight of strongly organic bases are added to the mixture for carbonylation. The reaction is carried out in a reactor having a circulation pump. The sodium salts, which are reaction products of the sodium methoxide, are removed by means of a filter. The filtrate is separated with the aid of rectification and the bottom product again subjected to carbonylation. The methyl formate results as the distillate, a high yield being achieved.
Patent AT-E134336-T1 (AT)
Inventor: KOK RONALDUS JOANNES CORNELIS
IPC: B29C45/00
Filed: 1993-06-08
Granted: 1996-03-15
Abstract: The invention relates to an installation for manufacturing registration carriers, provided with an injection moulding device (2) and with two holders (5,9) supporting moulding plates, which are adjustable with respect to each other between a first position, in which said moulding plates bound a mould cavity, into which a material can be injected by means of the injection moulding device during operation so as to form the registration carrier, and a second position, in which the moulding plates have been moved some distance apart with a view to removing the registration carrier formed. Transport means are provided on either side of the injection moulding device, by means of which a holder (9) supporting a moulding plate can be moved from a position located at some distance from the injection moulding device (2) to a position suitable for cooperation with the injection moulding device, and/or from a position suitable for cooperation with the injection moulding device to a position located at some distance from the injection moulding device. <IMAGE>
Patent AT-E178070-T1 (AT)
Inventor: CHEN MENG-HSIN
IPC: C07D221/20
Filed: 1993-12-08
Granted: 1999-04-15
Abstract: There are disclosed certain novel compounds identified as spiro piperidines and homologs which promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to treat physiological or medical conditions characterized by a deficiency in growth hormone secretion, such as short stature in growth hormone deficient children, and to treat medical conditions which are improved by the anabolic effects of growth hormone. Growth hormone releasing compositions containing such spiro compounds as the active ingredient thereof are also disclosed.
Patent AT-E192483-T1 (AT)
Inventor: HINNEKENS HERVE
IPC: C07C69/30
Filed: 1993-07-20
Granted: 2000-05-15
Abstract: The present invention provides a lubricating oil or a lubricating oil additive, particularly suitable for a R-134a (1,1,1,2-tetrafluoroethane) or R-134 (1,1,2,2-tetrafluoroethane) refrigerant, consisting of a compound (X) that can be prepared by esterification of a polyoxyethoxylated glycerol with at least one polycarboxylic acid compound having from 2 to 20 carbon atoms, preferably from 4 to 13 carbon atoms, and at least one monocarboxylic acid compound having from 2 to 20 carbon atoms, preferably from 6 to 13 carbon atoms.
Patent AT-E203058-T1 (AT)
Inventor: CHAPMAN JOHN R
IPC: C12N7/00
Filed: 1993-02-09
Granted: 2001-07-15
Abstract: The present invention provides a method for testing a blood unit for viral contamination without rendering the blood unit unusable for therapeutic applications. The method comprises the steps of: removing and collecting from a blood unit a majority of the leukocytes present therein with a leukocyte filter; and using the leukocytes collected in and on the filter to test the blood unit for viral contamination. The present invention also provides a method for validating viral inactivation processes.
Patent AT-E193418-T1 (AT)
Inventor: LIN LILY
IPC: A61J3/00
Filed: 1993-02-26
Granted: 2000-06-15
Abstract: Methods and compositions are described for treating contaminants in material intended for in vivo use, and in particular blood and blood products for human use. Contaminants in blood cell preparations are inactivated using 8-methoxypsoralen prior to long term storage and transfusion.
Patent AT-E139836-T1 (AT)
Inventor: SPECKBROCK GERD
IPC: G01K5/02
Filed: 1993-08-16
Granted: 1996-07-15
Abstract: A clinical thermometer with maximum function with a non-toxic eutectic Ga alloy as measuring fluid 14 inside a measuring tube 13 which provides adhesion forces larger than the cohesion forces inherent in liquid 14. To reach the maximum function, therefore, the customary Hick'sche constriction is not required any more facilitating production and handling of said clinical thermometer. Furthermore, a special Ga/In/Sn alloy is described, which may be used not only for clinical thermometers but also as a lubricant.
Patent AT-E211633-T1 (AT)
Inventor: TANSEY MICHAEL
IPC: A61M21/00
Filed: 1993-09-02
Granted: 2002-01-15
Abstract: A biofeedback system (10) provides detection of bioelectric signals in a range of 0-90 Hz. A bioelectric signal (26) is amplified by a preamplifier (22). The composite amplitude of the amplified signal (24) is calculated by performing a fast Fourier transform on the amplified signal to calculate amplitudes of bandwidths in the range of the detected signal. Particular bandwidths of interest can be selected and displayed on a computer (26). The display permits training of the person being monitored with audio or verbal feedback.
Patent AT-E133237-T1 (AT)
Inventor: AIGNER GEORG
IPC: F16B2/04
Filed: 1993-10-25
Granted: 1996-02-15
Abstract: PCT No. PCT/EP93/02943 Sec. 371 Date Aug. 15, 1994 Sec. 102(e) Date Aug. 15, 1994 PCT Filed Oct. 25, 1993 PCT Pub. No. WO94/05738 PCT Pub. Date Mar. 17, 1994A stop strip with a clamping member for fastening in a vertical groove of a protective hood for wood shaping machines. The clamping member is formed by a die which is connected with the stop strip and has a mushroom-shaped head which engages in a vertical groove having a C-shaped cross section. The head is formed by two head parts which are displaceable relative to one another and can be spread apart against the walls of the groove.